Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cell Cycle. 2012 May 15;11(10):2006-21. doi: 10.4161/cc.20423.
Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of a polyglutamine repeat within the HD gene product, huntingtin. Huntingtin, a large (347 kDa) protein containing multiple HEAT repeats, acts as a scaffold for protein-protein interactions. Huntingtin-induced toxicity is believed to be mediated by a conformational change in expanded huntingtin, leading to protein misfolding and aggregation, aberrant protein interactions and neuronal cell death. While many non-systematic studies of huntingtin interactions have been reported, they were not designed to identify and quantify the changes in the huntingtin interactome induced by polyglutamine expansion. We used tandem affinity purification and quantitative proteomics to compare and quantify interactions of normal or expanded huntingtin isolated from a striatal cell line. We found that proteins preferentially interacting with expanded huntingtin are enriched for intrinsically disordered proteins, consistent with previously suggested roles of such proteins in neurodegenerative disorders. Our functional analysis indicates that proteins related to energy production, protein trafficking, RNA post-transcriptional modifications and cell death were significantly enriched among preferential interactors of expanded huntingtin. Expanded huntingtin interacted with many mitochondrial proteins, including AIFM1, consistent with a role for mitochondrial dysfunction in HD. Furthermore, expanded huntingtin interacted with the stress granule-associated proteins Caprin-1 and G3BP and redistributed to RNA stress granules under ER-stress conditions. These data demonstrate that a number of key cellular functions and networks may be disrupted by abnormal interactions of expanded huntingtin and highlight proteins and pathways that may be involved in HD cellular pathogenesis and that may serve as therapeutic targets.
亨廷顿病(HD)是一种神经退行性疾病,由 HD 基因产物亨廷顿蛋白中的多聚谷氨酰胺重复扩展引起。亨廷顿蛋白是一种包含多个 HEAT 重复的大型(347 kDa)蛋白,作为蛋白质-蛋白质相互作用的支架。亨廷顿蛋白诱导的毒性被认为是由扩展的亨廷顿蛋白的构象变化介导的,导致蛋白质错误折叠和聚集、异常的蛋白质相互作用和神经元细胞死亡。虽然已经报道了许多非系统性的亨廷顿蛋白相互作用研究,但它们并不是为了识别和量化多聚谷氨酰胺扩展引起的亨廷顿蛋白相互作用组的变化而设计的。我们使用串联亲和纯化和定量蛋白质组学来比较和量化从纹状体细胞系中分离的正常或扩展的亨廷顿蛋白的相互作用。我们发现,与扩展的亨廷顿蛋白优先相互作用的蛋白质富含固有无序蛋白,这与这些蛋白质在神经退行性疾病中的先前建议作用一致。我们的功能分析表明,与能量产生、蛋白质运输、RNA 转录后修饰和细胞死亡相关的蛋白质在扩展的亨廷顿蛋白的优先相互作用物中显著富集。扩展的亨廷顿蛋白与许多线粒体蛋白相互作用,包括 AIFM1,这与 HD 中线粒体功能障碍有关。此外,扩展的亨廷顿蛋白与应激颗粒相关蛋白 Caprin-1 和 G3BP 相互作用,并在 ER 应激条件下重新分布到 RNA 应激颗粒中。这些数据表明,许多关键的细胞功能和网络可能会被扩展的亨廷顿蛋白异常相互作用破坏,并突出了可能涉及 HD 细胞发病机制的蛋白质和途径,这些蛋白质和途径可能作为治疗靶点。